Cargando…

Sphingosine-kinase-1 expression is associated with improved overall survival in high-grade serous ovarian cancer

PURPOSE: Sphingosine-kinase-1 (SPHK1) is a key enzyme of sphingolipid metabolism which is involved in ovarian cancer pathogenesis, progression and mechanisms of drug resistance. It is overexpressed in a variety of cancer subtypes. We investigated SPHK1 expression as a prognostic factor in epithelial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hanker, L. C., El-Balat, A., Drosos, Z., Kommoss, S., Karn, T., Holtrich, U., Gitas, G., Graeser-Mayer, M., Anglesio, M., Huntsman, D., Rody, A., Gevensleben, H., Hoellen, F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Article – Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021516/ https://www.ncbi.nlm.nih.gov/pubmed/33660008 http://dx.doi.org/10.1007/s00432-021-03558-x

Ejemplares similares

High-grade serous ovarian carcinoma organoids as models of chromosomal instability
por: Vias, Maria, et al.
Publicado: (2023)

Benign serous ovarian tumour: a redefining moment?
por: Hunter, Sally, et al.
Publicado: (2012)

Markers of T Cell Infiltration and Function Associate with Favorable Outcome in Vascularized High-Grade Serous Ovarian Carcinoma
por: Townsend, Katelin N., et al.
Publicado: (2013)

The Genomic Landscape of Early-Stage Ovarian High-Grade Serous Carcinoma
por: Cheng, Zhao, et al.
Publicado: (2022)

Genetics Consultation Rates Following a Diagnosis of High-Grade Serous Ovarian Carcinoma in the Canadian Province of Ontario
por: McGee, Jacob, et al.
Publicado: (2017)

Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes
por: Hunter, Sally M., et al.
Publicado: (2015)

Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study
por: Weir, Ashley, et al.
Publicado: (2022)

Treatment of Recurrent Epithelial Ovarian Cancer
por: Claussen, Carlota, et al.
Publicado: (2020)

First-Line Management of Advanced High-Grade Serous Ovarian Cancer
por: Mahmood, Reem D., et al.
Publicado: (2020)

T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers
por: Rody, Achim, et al.
Publicado: (2009)

Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma
por: Cooke, Susanna L, et al.
Publicado: (2010)

Population-based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high-grade serous ovarian cancer
por: Song, Honglin, et al.
Publicado: (2021)

Control of dataset bias in combined Affymetrix cohorts of triple negative breast cancer
por: Karn, Thomas, et al.
Publicado: (2014)

A clinically relevant gene signature in triple negative and basal-like breast cancer
por: Rody, Achim, et al.
Publicado: (2011)

Spatial cytotoxic and memory T cells in tumor predict superior survival outcomes in patients with high‐grade serous ovarian cancer
por: Zhang, Guodong, et al.
Publicado: (2021)

Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer
por: Xu, Junfen, et al.
Publicado: (2022)

Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas
por: Tone, Alicia A, et al.
Publicado: (2014)

A Robust Gene Expression Prognostic Signature for Overall Survival in High-Grade Serous Ovarian Cancer
por: Zhao, Yue, et al.
Publicado: (2019)

Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling
por: Bashashati, Ali, et al.
Publicado: (2013)

Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)

Comprehensive genomic profiling of high‐grade serous ovarian carcinoma from Chinese patients identifies co‐occurring mutations in the Ras/Raf pathway with TP53
por: Zhong, Fangfang, et al.
Publicado: (2019)

Impact of lymphadenectomy on short- and long-term complications in patients with endometrial cancer
por: Proppe, Louisa, et al.
Publicado: (2022)

Tumor genomic, transcriptomic, and immune profiling characterizes differential response to first‐line platinum chemotherapy in high grade serous ovarian cancer
por: Weberpals, Johanne I., et al.
Publicado: (2021)

Upfront debulking surgery for high-grade serous ovarian carcinoma: current evidence
por: Tsonis, Orestis, et al.
Publicado: (2020)

Prognostic gene expression signature for high-grade serous ovarian cancer
por: Millstein, J., et al.
Publicado: (2020)

Homogeneous Datasets of Triple Negative Breast Cancers Enable the Identification of Novel Prognostic and Predictive Signatures
por: Karn, Thomas, et al.
Publicado: (2011)

Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas
por: Sadlecki, Pawel, et al.
Publicado: (2018)

Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
por: Dey, Puja, et al.
Publicado: (2022)

Long-term satisfaction of patients after laparoscopic and robotic-assisted hysterectomy
por: Gitas, Georgios, et al.
Publicado: (2021)

The transcriptomic profile of ovarian cancer grading
por: Yao, Cindy Q, et al.
Publicado: (2015)

CCNG1 (Cyclin G1) regulation by mutant‐P53 via induction of Notch3 expression promotes high‐grade serous ovarian cancer (HGSOC) tumorigenesis and progression
por: Xu, Ying, et al.
Publicado: (2018)

Deregulation of MYCN, LIN28B and LET7 in a Molecular Subtype of Aggressive High-Grade Serous Ovarian Cancers
por: Helland, Åslaug, et al.
Publicado: (2011)

Preoperative CT-based deep learning model for predicting overall survival in patients with high-grade serous ovarian cancer
por: Zheng, Yawen, et al.
Publicado: (2022)

Primary ovarian leiomyoma: a rare ovarian tumour
por: Pervan, Mascha, et al.
Publicado: (2022)

Overexpression of the orphan nuclear receptor NR2F6 is associated with improved survival across molecular subgroups in endometrial cancer patients
por: Proppe, L., et al.
Publicado: (2023)

Outcome in serous ovarian cancer is not associated with LATS expression
por: Montavon, Céline, et al.
Publicado: (2019)

Stratification of ovarian cancer borderline from high-grade serous carcinoma patients by quantitative serum NMR spectroscopy of metabolites, lipoproteins, and inflammatory markers
por: Bae, Gyuntae, et al.
Publicado: (2023)

Synthetic lethality in CCNE1-amplified high grade serous ovarian cancer through combined inhibition of Polo-like kinase 1 and microtubule dynamics
por: Noack, Sabrina, et al.
Publicado: (2018)

Surgical staging and prognosis in serous borderline ovarian tumours (BOT): A subanalysis of the AGO ROBOT study
por: Trillsch, F, et al.
Publicado: (2015)

Development and validation of an individualized gene expression-based signature to predict overall survival of patients with high-grade serous ovarian carcinoma
por: Yuan, Dandan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7j26kng2joit7im0ni7irp26q7